• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4615257)   Today's Articles (1269)   Subscriber (49393)
For: Bouche O, Conroy T, Michel P, Penna C, Tournigand C. Metastatic colorectal cancer. ACTA ACUST UNITED AC 2006. [DOI: 10.1016/s0399-8320(06)73587-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Number Cited by Other Article(s)
1
Lamy S, Guimbaud R, Digue L, Cirilo-Cassaigne I, Bousser V, Oum-Sack E, Goddard J, Bauvin E, Delpierre C, Grosclaude P. Are there variations in adherence to colorectal cancer clinical guidelines depending on treatment place and recommendation novelty? The French EvaCCoR observational study. Clin Res Hepatol Gastroenterol 2019;43:346-356. [PMID: 30447905 DOI: 10.1016/j.clinre.2018.10.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/26/2018] [Revised: 08/29/2018] [Accepted: 10/15/2018] [Indexed: 02/04/2023]
2
Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort. Target Oncol 2015;11:83-92. [DOI: 10.1007/s11523-015-0377-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
3
Smith D, Terrebonne E, Rouyer M, Blanc JF, Breilh D, Pedeboscq S, Le Monies A, Lecomte C, Lassalle R, Moore N, Fourrier-Réglat A. Chemotherapy and targeted agents for colorectal cancer in a real-life setting anticipate guidelines: the COLCHIC cohort study. Fundam Clin Pharmacol 2011;27:113-9. [DOI: 10.1111/j.1472-8206.2011.00961.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
4
Bouché O, Beretta GD, Alfonso PG, Geissler M. The role of anti-epidermal growth factor receptor monoclonal antibody monotherapy in the treatment of metastatic colorectal cancer. Cancer Treat Rev 2010;36 Suppl 1:S1-10. [DOI: 10.1016/s0305-7372(10)00036-8] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
5
Bouché O, Scaglia E, Reguiai Z, Singha V, Brixi-Benmansour H, Lagarde S. [Targeted biotherapies in digestive oncology: management of adverse effects]. ACTA ACUST UNITED AC 2009;33:306-22. [PMID: 19345533 DOI: 10.1016/j.gcb.2009.02.008] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
6
Grève E, Dumas O, Fumex F, Cambou M, Burgard G, Décousus M, Audigier JC. [Solitary pancreatic metastasis four years after curative treatment for rectal carcinoma]. ACTA ACUST UNITED AC 2008;32:258-60. [PMID: 18456107 DOI: 10.1016/j.gcb.2008.01.012] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA